Cubist Systematic Strategies, LLC Ab Cellera Biologics Inc. Transaction History

Cubist Systematic Strategies, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$5.66 - $7.59 $299 - $402	-53 Reduced 0.23%	22,625 $146,000
Q1 2023 May 15, 2023	SELL	$7.31 - $11.18 $1.07 Million - $1.63 Million	-145,749 Reduced 86.54%	22,678 $170,000
Q4 2022 Feb 14, 2023	SELL	$9.48 - $14.52 $3.94 Million - $6.03 Million	-415,554 Reduced 71.16%	168,427 $1.71 Million
Q3 2022 Nov 14, 2022	BUY	$9.2 - $13.68 $1.74 Million - $2.58 Million	188,649 Added 47.72%	583,981 $5.78 Million
Q2 2022 Aug 15, 2022	BUY	$5.72 - $10.65 $852,445 - $1.59 Million	149,029 Added 60.51%	395,332 $4.21 Million
Q1 2022 May 16, 2022	SELL	$7.46 - $14.14 $122,217 - $231,655	-16,383 Reduced 6.24%	246,303 $2.4 Million
Q4 2021 Feb 14, 2022	BUY	$12.99 - $17.73 $2.93 Million - $4 Million	225,812 Added 612.39%	262,686 $3.76 Million
Q3 2021 Nov 15, 2021	SELL	$14.85 - $21.34 $3.32 Million - $4.77 Million	-223,485 Reduced 85.84%	36,874 $739,000
Q2 2021 Aug 16, 2021	BUY	$20.19 - $34.17 $4.48 Million - $7.58 Million	221,809 Added 575.38%	260,359 $5.73 Million
Q1 2021 May 17, 2021	BUY	$23.29 - $53.2 $897,829 - $2.05 Million	38,550 New	38,550 $1.31 Million

154

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $841M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.